Malaria vaccines to moderate the impact of antibiotic resistance in endemic countries
Journal of Medical Microbiology · 2023
DOI: 10.1099/jmm.0.001734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2023. Verfasst von Maria Khan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Peshawar Institute of Cardiology - MTI, Peshawar, Pakistan. Hauptthemen laut MEDLINE: Malaria Vaccines, Malaria, Falciparum, Malaria. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Swift and widespread deployment of an efficient malaria vaccine in Pakistan, together with basic control and preventive measures, could significantly decrease the economic and healthcare burden caused by drug-resistant malaria. Moreover, the RTS,S/AS01 vaccine has provided a much needed breakthrough after decades of growth, as an innovative vaccine for malaria in phase 3 clinical trials and currently undergoing implementation studies. Vaccination is a potentially critical component of efforts to arrest the development and dissemination of antimicrobial resistance, although little is known about the impact vaccination may have within low- and-middle-income countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peshawar Institute of Cardiology - MTI, Peshawar, Pakistan.
Zitieren
APA
Khan, M., & Khan, S. (2023). Malaria vaccines to moderate the impact of antibiotic resistance in endemic countries. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001734
Vancouver
Khan M, Khan S. Malaria vaccines to moderate the impact of antibiotic resistance in endemic countries. Journal of Medical Microbiology. 2023. doi:10.1099/jmm.0.001734
BibTeX
@article{Khan2023,
author = {Khan, Maria and Khan, Saba},
title = {Malaria vaccines to moderate the impact of antibiotic resistance in endemic countries},
journal = {Journal of Medical Microbiology},
year = {2023},
doi = {10.1099/jmm.0.001734}
}
EUVIMED